Effect of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis
Levonorgestrel-releasing intrauterine system treatment of adenomyosis significantly reduced menstrual bleeding, uterine volume, and dysmenorrhea, with anemic patients showing improved hemoglobin levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The paper evaluated the clinical efficacy of a levonorgestrel-releasing intrauterine system (LNG-IUS; Mirena) for treating adenomyosis in 42 patients diagnosed by clinical symptoms plus color ultrasound or MRI and confirmed using laparoscopy or open surgery. After LNG-IUS placement, outcomes included menstrual blood loss, dysmenorrhea severity, and uterine volume measured over a 3-month follow-up. At 3 months, menstrual blood loss decreased to about 27±11% of baseline, uterine volume fell from 143±33 cm3 to 115±22 cm3, and dysmenorrhea was significantly improved or resolved in all patients, with hemoglobin recovering in 20 anemic patients. The paper states overall that the recent treatment effect was significant, but it is limited by its short observation period and lacks a control/comparator group. This paper is centrally about adenomyosis — it specifically examines LNG-IUS clinical outcomes in patients with uterine adenomyosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
531 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (10)
- Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis 2021
- Adenomiosis: tratamiento 2015
- Mise au point sur l’adénomyose 2012
- Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis 2012
- Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis 2011
- Hormonal treatments for adenomyosis 2007
- Tratamiento de la adenomiosis 2007
- Traitement de l'adénomyose 2007
- New interventional techniques for adenomyosis 2006
- Adénomyose 2006
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00